Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bouman

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Critical Care Medicine|October 24, 2002
Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trialCatherine S C Bouman, Heleen M Oudemans-Van Straaten, Jan G P Tijssen, et al.
Journal of Vascular Surgery|July 8, 2014
Acute kidney injury defined according to the 'Risk,' 'Injury,' 'Failure,' 'Loss,' and 'End-stage' (RIFLE) criteria after repair for a ruptured abdominal aortic aneurysmSytse C van Beek, Dink A Legemate, Anco Vahl, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 1, 2013
[Necrotising soft-tissue infections: diagnostics and treatment]Frank P Garssen, J Carel Goslings, Catherine S C Bouman, et al.
Critical Care (London, England)|October 20, 2012
A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically ill patientsKama A Wlodzimirow, Ameen Abu-Hanna, Mathilde Slabbekoorn, et al.
Intensive Care Medicine|October 18, 2006
Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosingCatherine S C Bouman, Hendrikus J M van Kan, Richard P Koopmans, et al.
Intensive Care Medicine|May 23, 2003
Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsisAnne Cornélie J M de Pont, Catherine S C Bouman, Evert de Jonge, et al.
International Journal of Antimicrobial Agents|January 1, 2017
Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysisCaspar J Hodiamont, Nicole P Juffermans, Catherine S C Bouman, et al.
Surgical and Radiologic Anatomy : SRA|April 27, 2017
Boundaries of the thoracic paravertebral space: potential risks and benefits of the thoracic paravertebral block from an anatomical perspectiveEsther A C Bouman, Judith M Sieben, Andrea J R Balthasar, et al.
Thrombosis Research|July 1, 2014
Biomarkers for post thrombotic syndrome: a case-control studyA C Bouman, Y W Cheung, H M Spronk, et al.
Thrombosis Research|November 22, 2015
Clot structure and fibrinolytic potential in patients with post thrombotic syndromeA C Bouman, H McPherson, Y W Cheung, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Critical Care Medicine|October 24, 2002
Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trialCatherine S C Bouman, Heleen M Oudemans-Van Straaten, Jan G P Tijssen, et al.
Journal of Vascular Surgery|July 8, 2014
Acute kidney injury defined according to the 'Risk,' 'Injury,' 'Failure,' 'Loss,' and 'End-stage' (RIFLE) criteria after repair for a ruptured abdominal aortic aneurysmSytse C van Beek, Dink A Legemate, Anco Vahl, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 1, 2013
[Necrotising soft-tissue infections: diagnostics and treatment]Frank P Garssen, J Carel Goslings, Catherine S C Bouman, et al.
Critical Care (London, England)|October 20, 2012
A comparison of RIFLE with and without urine output criteria for acute kidney injury in critically ill patientsKama A Wlodzimirow, Ameen Abu-Hanna, Mathilde Slabbekoorn, et al.
Intensive Care Medicine|October 18, 2006
Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosingCatherine S C Bouman, Hendrikus J M van Kan, Richard P Koopmans, et al.
Intensive Care Medicine|May 23, 2003
Treatment with recombinant human activated protein C obviates additional anticoagulation during continuous venovenous hemofiltration in patients with severe sepsisAnne Cornélie J M de Pont, Catherine S C Bouman, Evert de Jonge, et al.
International Journal of Antimicrobial Agents|January 1, 2017
Determinants of gentamicin concentrations in critically ill patients: a population pharmacokinetic analysisCaspar J Hodiamont, Nicole P Juffermans, Catherine S C Bouman, et al.
Surgical and Radiologic Anatomy : SRA|April 27, 2017
Boundaries of the thoracic paravertebral space: potential risks and benefits of the thoracic paravertebral block from an anatomical perspectiveEsther A C Bouman, Judith M Sieben, Andrea J R Balthasar, et al.
Thrombosis Research|July 1, 2014
Biomarkers for post thrombotic syndrome: a case-control studyA C Bouman, Y W Cheung, H M Spronk, et al.
Thrombosis Research|November 22, 2015
Clot structure and fibrinolytic potential in patients with post thrombotic syndromeA C Bouman, H McPherson, Y W Cheung, et al.
Pageof 6